|Low Dose Naltrexone Therapy|
Promising New Therapy for MS & Immune
2010 Two studies show LDN benefits. The LDN study from Penn State, and the human trial of LDN at UCSF. Thank you fellow LDNers for funding 50% of the UCSF trial!
International LDN Awareness Week
(More LDN News below...)
My name is SammyJo, I'm an MS patient who has experienced remarkable recovery from MS misery. Research is proving that using a low dose of the FDA approved drug Naltrexone is helpful in treating many immune system disorders. LDNers.org is dedicated to helping patients get better with LDN.
Join SammyJo on Facebook
Your LDN Results
Annual LDN Conference
Annual LDN Conference and
There are exciting developments in Low Dose Naltrexone (LDN) research. Visit the Research section for details on:
Publication of the first medical hypothesis on LDN therapy for MS
Status of clinical trials for LDN
First Annual LDN Conference June 11th 2005 in NYC
Patient Initiated Research / Evidence-based Medicine
Four key questions answered by 267 LDN users in Survey 1:
I started this site in the Spring of 2004 to confirm that others were seeing the same positive results I was. Thank you to the hundreds of LDNers contributing their experiences. I hope scientific research will accelerate and determine why so many of us are experiencing positive results.
Change in EDSS disability score before & after LDN is measured by Survey 2.
Follow the Surveys link for result details.
The surveys are comprised of a representative sampling of all types of MS (RRMS, SPMS, PPMS). This is important information from patients on the frontlines, and must be followed up by clinical researchers.
Naltrexone is an FDA-approved drug. LDN is an off-label use of naltrexone in a low dosage. It does requires a prescription from a doctor. See Resources for help finding a prescriber or pharmacy, and info on LDN for other autoimmune disorders, cancer or HIV.
Copyright © 2006-2009 LDNers.org. All rights reserved